Biography

Dr. Lin is a multiple sclerosis specialist trained under the distinguished MS experts Dr. Robert Lisak of Wayne State University and Dr. Lilyana Amezcua of University of Southern California. She was awarded a MS fellowship by the National MS Society. During her training, she was a recipient of several competitive scholarships funded by the American Academy of Neurology as well as the Consortium of Multiple sclerosis Centers. She has conducted clinical research in MS and provided expert reviews in neurology journals. She is an avid educator of neurological disorders and is interested in training future generation of MS providers.

Education

Medical Degree
University of Colorado, School of Medicine - Aurora, CO
Masters in Public Health
Health Systems, Management & Policy, University of Colorado, School of Public Health - Aurora, CO
Residency
Neurology, Wayne State University - Detroit, MI
Fellowship
Multiple Sclerosis and Neuroimmunology, University of Southern California - Los Angeles, CA

Areas of Interest

Clinical Interests

  • Multiple sclerosis (MS)
  • Neuromyelitis optica (NMO)
  • Myelin oligodendrocyte glycoprotein antibody-associated diseases (MOGAD) Autoimmune encephalitis
  • Neurosarcoidosis

Research Interests

  • COVID-19 infections in MS
  • Pregnancy and breastfeeding in MS and related autoimmune CNS disorders
  • MS in minorities

Publications

  1. Farhan Chaudhry, Helena Bulka, Anirudha S. Rathnam, Omar M Said, Jia Lin, Holly Lorigan, Eva Bernitsas, Jacob Rube, Steven J Korzeniewski, Anza B Memon, Phillip D. Levy, Adil Javed, Robert Lisak, Mirela Cerghet. COVID-19 in Multiple Sclerosis Patients and Risk Factors for Severe Infection. Journal of Neurological Sciences 2020; 418: 117147
  2. Yang IV, Coldren CD, Leach SM, Seibold MA, Murphy E, Lin, J, Rosen R, Neidermyer AJ, McKean DF, Groshong SD, Cool C, Cosgrove GP, Lynch DA, Brown KK, Schwarz MI, Fingerling TE, and Schwartz DA. Expression of cilium- associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis. Thorax 2013 Dec; 68 (12): 1114-21.
  3. Max A. Seibold, Lauranell H. Burch, Jia Lin, Corinne E. Hennessy, Marvin I. Schwarz, and David A. Schwartz. Common polymorphism in MUC5B promoter is a risk factor for the development of familial interstitial pneumonia (FIP) and idiopathic pulmonary fibrosis (IPF). N Engl J Med 2011; 364:1503-1512